CHADS 2 and CHA 2DS 2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients

American Journal of Cardiology

Volumn 109, Issue 10, 2012, Pages 1526-1533

  Naccarelli, Gerald V ^a   Panaccio, Mary Prince ^c   Cummins, Gordon ^b   Tu, Nora ^c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b IQVIA   (United States)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART SURGERY; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCORING SYSTEM; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; HEART FAILURE; INCIDENCE; METHODOLOGY; MORTALITY; RISK ASSESSMENT; SURVIVAL RATE; UNITED STATES;

ATRIAL FIBRILLATION; ATRIAL FLUTTER; HEART FAILURE; HOSPITALIZATION; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84860470563     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.01.371     Document Type: Review

References (29)

1. G.V. Naccarelli, H. Varker, J. Lin, K.L. Schulman Increasing prevalence of atrial fibrillation and flutter in the United States Am J Cardiol 104 2009 1534 1539
2. W.A. Wattigney, G.A. Mensah, J.B. Croft Increasing trends in hospitalization for atrial fibrillation in the United States 1985 through 1999: implications for primary prevention Circulation 108 2003 711 716
3. Y. Miyasaka, M.E. Barnes, B.J. Gersh, S.S. Cha, K.R. Bailey, W.P. Abhayaratna, J.B. Seward, T.S. Tsang Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125
4. Y. Miyasaka, M.E. Barnes, B.J. Gersh, S.S. Cha, K.R. Bailey, J.B. Seward, T.S. Tsang Changing trends of hospital utilization in patients after their first episode of atrial fibrillation Am J Cardiol 102 2008 568 572
5. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, T.M. Brown, M.R. Carnethon, S. Dai, G. De Simone, E.S. Ford, C.S. Fox, H.J. Fullerton, C. Gillespie, K.J. Greenlund, S.M. Hailpern, J.A. Heit, P.M. Ho, V.J. Howard, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D.M. Makuc, G.M. Marcus, A. Marelli, D.B. Matchar, M.M. McDermott, J.B. Meigs, C.S. Moy, D. Mozaffarian, M.E. Mussolino, G. Nichol, N.P. Paynter, W.D. Rosamond, P.D. Sorlie, R.S. Stafford, T.N. Turan, M.B. Turner, N.D. Wong, J. Wylie-Rosett Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 459 463
6. G.V. Naccarelli, S.S. Johnston, J. Lin, P.P. Patel, K.L. Schulman Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States Clin Cardiol 33 2010 270 279
7. W.C. Lee, G.A. Lamas, S. Balu, J. Spalding, Q. Wang, C.L. Pashos Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective J Med Econ 11 2008 281 298
8. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
9. V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, G.N. Kay, J.Y. Le Huezey, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, L.S. Wann 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society J Am Coll Cardiol 57 2011 e101 e198
10. M.A. Crandall, B.D. Horne, J.D. Day, J.L. Anderson, J.B. Muhlestein, B.G. Crandall, J.P. Weiss, J.S. Osborne, D.L. Lappe, T.J. Bunch Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors Pacing Clin Electrophysiol 32 2009 981 986
11. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
12. Thompson Reuters MarketScan studies, abbreviated bibliography http://img.en25.com/Web/ThomsonReuters/2011MarketScanBibliography.pdf Accessed May 9, 2011
13. SAS Institute Inc The LOGISTIC procedure SAS/STAT 9.2 User's Guide 2nd ed. 2009 SAS Institute Inc. Cary, North Carolina 3255 3476
14. SAS Institute Inc The PHREG procedure SAS/STAT 9.2 User's Guide 2nd ed. 2009 SAS Institute Inc. Cary, North Carolina 4521 4730
15. D.W. Hosmer, S. Lemeshow Applied Logistic Regression 2000 John Wiley New York, New York
16. SAS Institute Inc The LIFETEST procedure SAS/STAT 9.2 User's Guide 2nd ed. 2009 SAS Institute Inc. Cary, North Carolina 3099 3186
17. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, J.V. Selby, D.E. Singer Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
18. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, I. van Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. De Caterina, J. De Sutter, A. Goette, B. Gorenek, M. Heldal, S.H. Hohloser, P. Kolh, J.Y. Le Heuzey, P. Ponikowski, F.H. Rutten, A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, P.E. Vardas, P. Widimsky, P.E. Vardas, V. Agladze, E. Aliot, T. Balabanski, C. Blomstrom-Lundqvist, A. Capucci, H. Crijns, B. Dahlof, T. Folliguet, M. Glikson, M. Goethals, D.C. Gulba, S.Y. Ho, R.J. Klautz, S. Kose, J. McMurray, P. Perrone Filardi, P. Raatikainen, M.J. Salvador, M.J. Schalij, A. Shpektor, J. Sousa, J. Stepinska, H. Uuetoa, J.L. Zamorano, I. Zupan Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
19. M.R. Reynolds, V. Essebag, P. Zimetbaum, D.J. Cohen Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry J Cardiovasc Electrophysiol 18 2007 628 633
20. P.A. Wolf, J.B. Mitchell, C.S. Baker, W.B. Kannel, R.B. D'Agostino Impact of atrial fibrillation on mortality, stroke, and medical costs Arch Intern Med 158 1998 229 234
21. E.Q. Wu, H.G. Birnbaum, M. Mareva, E. Tuttle, A.R. Castor, W. Jackman, J. Ruskin Economic burden and co-morbidities of atrial fibrillation in a privately insured population Curr Med Res Opin 21 2005 1693 1699
22. S.H. Hohnloser, H.J. Crijns, M. van Eickels, C. Gaudin, R.L. Page, C. Torp-Pedersen, S.J. Connolly Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
23. L.S. Wann, A.B. Curtis, C.T. January, K.A. Ellenbogen, J.E. Lowe, N.A. Estes III, R.L. Page, M.D. Ezekowitiz, D.J. Slotwiner, W.M. Jackman, W.G. Stevenson, C.M. Tracy 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 104 123
24. L. Kober, C. Torp-Pedersen, J.J. McMurray, O. Gotzsche, S. Levy, H. Crijns, J. Amlie, J. Carlsen Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687
25. Sanofi provides Multaq phase IIIb PALLAS trial update http://en.sanofi.com/binaries/20110707-PALLAS-en-tcm28-33021.pdf Accessed July 13, 2011
26. A. Alonso, S.K. Agarwal, E.Z. Soliman, M. Ambrose, A.M. Chamberlain, R.J. Prineas, A.R. Folsom Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study Am Heart J 158 2009 111 117
27. P.C. Austin, P.A. Daly, J.V. Tu A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario Am Heart J 144 2002 290 296
28. A.M. Borzecki, D.K. Bridgers, J.M. Liebschutz, B. Kader, L.E. Kazis, D.R. Berlowitz Racial differences in the prevalence of atrial fibrillation among males J Natl Med Assoc 100 2008 237 245
29. L. Boulanger, O. Hauch, M. Friedman, T. Foster, D. Dixon, G. Wygant, J. Menzin Warfarin exposure and the risk of thromboembolic and major bleeding events among Medicaid patients with atrial fibrillation Ann Pharmacother 40 2006 1024 1029